"Scientists have developed what they call a virus cocktail to fight superbugs in a major advance for infectious disease treatment. Researchers from Monash University and The Alfred, in Melbourne, Australia, have developed a product that uses bacterial viruses, known as bacteriophages', to combat antimicrobial-resistant bacteria. The treatment, named Entelli-02, is a five-phage cocktail designed specifically to target Enterobacter cloacae complex (ECC), a group of bacteria responsible for severe, less treatable infections."
"Entelli-02 is a five-phage cocktail designed specifically to target ECC bacteria (Monash Biomedicine Discovery Institute) This is the first time we've designed and developed a clinical-ready phage therapy product tailored to an AMR bacterial pathogen at a local hospital, said Professor Jeremy J. Barr, who led the study published in Nature Microbiology. Entelli-02 is not just a scientific achievement, it's a clinical tool built for frontline use against deadly, drug-resistant, bacterial pathogens."
The Independent emphasizes on-the-ground journalism across issues like reproductive rights, climate change and Big Tech and requests donations to fund reporters while keeping content free of paywalls. Researchers at Monash University and The Alfred in Melbourne developed Entelli-02, a five-phage bacteriophage cocktail aimed at Enterobacter cloacae complex (ECC), which causes severe, hard-to-treat infections. The product uses bacteriophages to target antimicrobial-resistant bacteria and was developed with clinical readiness in mind at a local hospital setting. Entelli-02 is presented as both a scientific advancement and a frontline clinical tool against deadly, drug-resistant bacterial pathogens.
Read at www.independent.co.uk
Unable to calculate read time
Collection
[
|
...
]